Growth Policies for Biopharmaceutical Companies : A Dynamic Problem Definition

  • Martin U. Gropmann

Abstract

This working paper is an excerpt of the author's Ph.D. dissertation. The excerpt starts with categorizing biopharmaceutical companies according to research technologies applied in drug discovery. Discovery is the earliest phase in pharmaceutical R&D pipelines. The major strategic problem of biopharmaceutical high-technology firms is caused by the length of… (More)

Topics

16 Figures and Tables

Slides referencing similar topics